AI and cognitive computing digital tech for MedTech industries

DIGI-B-CUBE, funded by Horizon 2020, will facilitate the identification of AI and cognitive computing digital tech which can be applied by the Bioimaging, Biosensing and Biobanking industries.

Besides providing resources for the development of cutting-edge solutions, DIGI-B-CUBE will facilitate the identification of Artificial Intelligence (AI) and cognitive computing digital tech which can be applied by the Bioimaging, Biosensing and Biobanking industries through a matchmaking platform which is scheduled to be launched in April 2020.

DIGI-B-CUBE project, funded under Program Horizon 2020 by European Union (EU), will foster the creation of solutions by providing innovative small and medium enterprises (SME) in the EU and associate countries with access to vouchers of up to €60,000 to develop prototypes and customised solutions for the health sector.

The voucher scheme call will be launched in April 2020, but SMEs can start engaging in the project activities in the coming months by joining the project´s sectoral and cross-sectoral workshops, as well as, matchmaking sessions. Through DIGI-B-CUBE website, companies will also be able to interact with the consortium, identify potential partner SMEs, access digital services and contribute for the elaboration of an action plan that suits their needs.

Read the full article on https://www.healtheuropa.eu/digi-b-cube-ai-cognitive-computing-digital-tech/92160/

More info about innovation vouchers? Contact us at info@medtech-wallonia.be

Spentys strives to revolutionise the orthopaedic immobilisation device industry

Interview with Louis-Philippe Broze & Florian De Boeck

What would be your two-minute elevator pitch?

At Spentys, we strive to revolutionise the orthopaedic immobilisation device industry by introducing 3D technologies. We want the industry to shift from traditional design processes to new ones which includes 3D technologies – think scanning, modelling and printing. That’s why we’ve developed our three-step solution, all centralised on a web platform. The Spentys solution allows mass-customisation of orthopaedic immobilisation devices, while considering and implementing the medical expertise of health professionals.

To make the solution accessible to the market, Spentys has developed and clinically tested 3D printed orthopaedic immobilisation devices – plasters, splints, and whatnot – on various limbs. The end results are water-resistant, airy, light, custom-made and completely recyclable devices. So all in all, way more comfort for the patient!

List three factors that make Brussels’ entrepreneurship landscape unique.

What we particularly cherish in Brussels is its diversity: it’s not a big region in terms of size compared to other major entrepreneurial hubs, but we still have access to a very diverse micro-market, where citizen and corporate needs may vary a lot. This can be explained through various factors, such as Brussels being the capital of the EU and thus welcoming people from around the globe. Or the fact that it’s a bilingual region.

It appears that Brussels attracts a lot of foreign talents. Specific to Spentys, we have been able to meet our HR needs quickly with awesome, skilled young profiles. This can be explained by Brussels’ high quality of life in and amongst its citizens.

Brussels is a medium-sized city, making it easy to create a diverse network within the entrepreneurial ecosystem. Also, as an entrepreneur, you can find a broad network with all the necessary expertise quickly.

What are the three biggest challenges you faced when starting up your business?

Bureaucracy and administration can sometimes be a pain in the … As an entrepreneur, you’d like to spend your time focussing on the core of your business, and not on filling your taxes, for example.

A second major aspect when starting your business is time management: you must be able to allocate your time to meaningful tasks which will help your business grow. So, you need to learn how to identify them from other tasks.

And finally, managing a team – especially if you’ve never done it before, or there are varying opinions within your team. You must learn patience.  

hub.brussels have been our entry point into Brussel’s entrepreunarial ecosystem.

How did you benefit from hub.brussels’ expertise in the conception of your business?

In various ways; the main one being the fact that we are part of lifetech.brussels, hub.brussels’ health tech cluster. This gave us the opportunity to participate in the six-month long MedTech Accelerator initiative when we first founded Spentys and showed us a global vision of what it would be like to introduce a new medical device on the EU market. hub.brussels also helped us reach public financing opportunities, through grants and convertible loans. To sum up, they have been our entry point into Brussels’ entrepreneurial ecosystem.

List three pieces of advice you would give to the budding entrepreneur.

We’re both budding entrepreneurs ourselves, since we started Spentys only two years ago. With our short experience, we can give the following points of advice:

Stay focussed on one main goal and the necessary steps to achieve them. You can pivot, but always make sure to consult with experts beforehand.

Do not underestimate the time required to raise funds, and always raise more than you need. This will give you more time for the next round of negotiation.

And finally, you must learn to listen to the people around you and be open to criticism, even if it’s “your” start-up. Listen and turn others’ remarks and comments into constructive criticism.

SPENTYS

Rue Saint-Denis 120 Sint-Denijsstraat (1190)

www.spentys.com

https://www.polemecatech.be/fr/member/spentys/

Belgian startup Osimis innovates with a new collaborative medical imaging software

Art Liège-based Osimis uses open source software to build innovative collaboration tools for medical imaging. Its newest solution, Lify, simplifies the exchange and consultation of medical imaging studies. The startup has just completed its third round of financing of €2.3 million to further the development of the Lily platform.

“We found in Lify a certain flexibility, responsiveness and customization of the tool that goes beyond the robustness of the system that had already been validated by our IT teams,” said Patrice Sapey, Director of the Saint-Catherine Cancer Institute in Avignon.

An expert in a global niche market, Osimis aims to strengthen its presence in Europe, North America and Asia. The Osimis team is the main contributor to the Orthanc open source project for medical imaging. Orthanc has been downloaded more than 230,000 times and is used in 192 countries. Lifyis Osimis’ proprietary platform that allows for a fast and efficient deployment of Orthanc in the health industry.

“As an initiator of the project in an academic setting thanks to the support of the University Hospital of Liège, I am delighted that we are thus opening a new page in the already long history of the free and open-source Orthanc ecosystem,” said Sébastien Jodogne, Chief Scientific Officer. “The scientific and societal impact of Orthanc has been praised internationally and is part of a philosophy of openness and dissemination of knowledge.”

​”This fundraising will enable us to accelerate the development and international expansion of the Lify platform,” said Frédéric Lambrechts, CEO. “Our goal is to improve the clinical pathway and the patient’s life across all dimensions of medical imaging. Technology and innovation are tools that must be put to the service of the patient. Our approach to this effect is to bring algorithmic innovation closer to clinical practice in the context of medical imaging. We’re currently looking for computer scientists and commercial medical technology to keep up with demand.”